2
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Prostatic Neoplasms
14
Neoplasms
8
Breast Neoplasms
5
Hypogonadism
3
Eunuchism
3
Testicular Neoplasms
2
Polycystic Ovary Syndrome
2
Obesity
2
Metabolic Syndrome
2
Fatigue
2
Dyspareunia
2
Arthralgia
2
Vaginitis
1
Sleep Apnea, Obstructive
1
Sleep Apnea Syndromes
1
Sexuality
1
Sexual Dysfunction, Physiological
1
Sarcopenia
1
Osteoporosis
1
Non-alcoholic Fatty Liver Disease
1
Neoplasm Metastasis
1
Muscle Weakness
1
Multiple Endocrine Neoplasia Type 1
1
Motor Activity
1
Metabolic Diseases
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma
1
Infertility
1
Hot Flashes
1
Diabetes Mellitus
1
Interventions
Psychiatric Rehabilitation
5
Counseling
4
Surveys and Questionnaires
2
Sildenafil Citrate
2
methyl N-acetylsibirosaminide
1
exemestane
1
black cohosh root extract
1
Therapeutics
1
Testosterone Propionate
1
Testosterone
1
Tamoxifen
1
Sexual Health
1
Restraint, Physical
1
Radiotherapy
1
Prostatectomy
1
Pilocarpine
1
Phentolamine
1
Papaverine
1
Oncology Nursing
1
Mental Status and Dementia Tests
1
High-Energy Shock Waves
1
Educational Status
1
Diet Therapy
1
Aromatase Inhibitors
1
Arginine
1
ArginMax
1
Alprostadil
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Sexuality
×
Testosterone
×
Clear all
NCT04492553
2022-11-29
Vitality
Herlev Hospital
Phase 2
Completed
7 enrolled